ACN Accenture plc - Fundamental Analysis
NEUTRAL
Sign in to save
Save this symbol to a watchlist or track a position.
ACN Stock | Fundamental Analysis & Investment Insights
NYSE
Technology
Information Technology Services
Current Price
Live
$281.07
Analyst Target
$291.42
+3.7%
Upside
52W High
$398.35
52W Low
$229.4
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Jan 24, 2026
Market cap
$174.3B
P/E
23.58
ROE
25.0%
Profit margin
10.8%
Debt/Equity
0.26
Dividend yield
2.29%
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
72%
Analysis Accuracy
Accenture's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite solid profitability metrics like a 25.02% ROE and manageable 0.26 Debt/Equity ratio, earnings growth is weakening with a -1.60% YoY decline and bearish insider activity. The stock trades at a significant premium to its Graham Number of $115.99 and intrinsic value of $83.44, currently priced at $281.07, though it remains below the analyst target of $291.42. Mixed signals from strong historical earnings beats (3 out of last 4 quarters) and recent positive EPS growth contrast with deteriorating technical trends and negative insider sentiment.
Key Strengths
Strong return on equity (25.02%) indicating efficient use of shareholder capital
Consistently beats earnings estimates, with 3 out of last 4 quarters showing positive surprises
Low leverage with Debt/Equity ratio of 0.26, suggesting conservative capital structure
Solid operating cash flow generation implied by high operating margin (16.97%)
Attractive dividend yield of 2.29% with sustainable 50.17% payout ratio
Key Risks
Weak Piotroski F-Score of 4/9 signals potential financial instability and operational inefficiencies
Earnings declining YoY (-1.60%) and QoQ (-3.00%), raising concerns about near-term profitability
Bearish technical trend (0/100) and price down 21.9% over the past year
Insider selling activity totaling $2.11M in the last 6 months, signaling lack of confidence
Significant valuation premium: trading at $281.07 vs Graham Number of $115.99 and intrinsic value of $83.44
AI Fair Value Estimate
Based on comprehensive analysis
$115.99
-58.7% below current price
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
56
Moderate
35
50
75
52
70
AI Verdict
Neutral with upside risk if growth reaccelerates
Key drivers: High profitability metrics, Weak earnings growth, Bearish insider activity, Premium valuation, Stable balance sheet
Confidence
70%
Value
35/100
Ref P/E, PEG, Graham Number
Positives
- Lower forward P/E of 18.88 suggests improving valuation outlook
Watchpoints
- Current P/E of 23.58 above sector average despite lower growth
- Price/Sales of 2.46 not justified by 6% revenue growth
- Stock trades at 2.4x Graham Number ($115.99)
Future
50/100
Ref Growth rates
Positives
- Recent Q/Q EPS growth of +30.0% indicates potential rebound
- Analyst target price implies 3.7% upside
Watchpoints
- Revenue growth slowing at 6.00% YoY
- Earnings declining YoY (-1.60%) and QoQ (-3.00%)
Past
75/100
Ref Historical trends
Positives
- 22 out of 25 quarters beat or meet earnings estimates
- Long-term track record of consistent earnings delivery
- Average earnings surprise of +4.29% over last 4 quarters
Watchpoints
- Most recent quarter missed estimates (-0.9%)
Health
52/100
Ref Altman Z-Score, Piotroski F-Score
Positives
- Current ratio of 1.41 and quick ratio of 1.29 indicate adequate liquidity
- Debt/Equity of 0.26 is conservative
Watchpoints
- Piotroski F-Score of 4/9 indicates weak financial health
- Altman Z-Score unavailable, limiting distress risk analysis
Dividend
70/100
Ref Yield, Payout
Positives
- Dividend yield of 2.29% above market average
- Payout ratio of 50.17% is sustainable
- Dividend strength score of 50/100 indicates moderate reliability
Watchpoints
- No 5-year average yield data to assess consistency
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$281.07
Analyst Target
$291.42
Upside/Downside
+3.7%
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for ACN and closest competitors.
Updated 2026-01-23
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
ACN
Accenture plc
Primary
|
+19.4% | +6.6% | -21.9% | -0.7% | +4.1% | -1.8% |
|
TXN
Texas Instruments Incorporated
Peer
|
+26.8% | +19.6% | +5.6% | -10.1% | +9.8% | +0.7% |
|
ADI
Analog Devices, Inc.
Peer
|
+143.3% | +101.1% | +48.0% | +41.8% | +16.4% | +5.3% |
|
QCOM
QUALCOMM Incorporated
Peer
|
+8.4% | +41.9% | +1.0% | +4.1% | -7.5% | -10.3% |
|
ANET
Arista Networks, Inc.
Peer
|
+609.0% | +347.9% | +5.6% | +19.3% | +4.3% | +5.0% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
23.58
Forward P/E
18.88
PEG Ratio
N/A
P/B Ratio
5.6
P/S Ratio
2.46
EV/Revenue
2.44
EV/EBITDA
13.85
Market Cap
$174.3B
Profitability
Profit margins and return metrics
Profit Margin
10.76%
Operating Margin
16.97%
Gross Margin
31.97%
ROE
25.02%
ROA
11.12%
Growth
Revenue and earnings growth rates
Revenue Growth
+6.0%
Earnings Growth
-1.6%
Q/Q Revenue Growth
N/A
Q/Q Earnings Growth
-3.0%
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
0.26
Low debt
Current Ratio
1.41
Good
Quick Ratio
1.29
Good
Cash/Share
$15.69
Quarterly Earnings History
EPS performance vs analyst estimates
2026-03-19
$N/A
2025-12-18
$3.94
+5.9% surprise
2025-09-25
$3.03
+2.0% surprise
2025-06-20
$3.49
+5.0% surprise
Technology Sector Comparison
Comparing ACN against 149 companies in the Technology sector
(11 bullish, 67 neutral, 71 bearish)
P/E Ratio
23.58
This Stock
vs
80.58
Sector Avg
-70.7%
(Discount)
Return on Equity (ROE)
25.02%
This Stock
vs
-6.46%
Sector Avg
-487.0%
(Below Avg)
Profit Margin
10.76%
This Stock
vs
-9.26%
Sector Avg
-216.2%
(Weaker)
Debt to Equity
0.26
This Stock
vs
0.7
Sector Avg
-63.2%
(Less Debt)
Revenue Growth
6.0%
This Stock
vs
61.74%
Sector Avg
-90.3%
(Slower)
Current Ratio
1.41
This Stock
vs
3.39
Sector Avg
-58.4%
(Weaker)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
ACN
Accenture plc
|
NEUTRAL | $174.3B | 23.58 | 25.0% | 10.8% | $281.07 | |
|
TXN
Texas Instruments Incorporated
|
NEUTRAL | $174.17B | 34.96 | 29.8% | 29.2% | $191.58 | |
|
ADI
Analog Devices, Inc.
|
BEARISH | $173.84B | 78.2 | 7.9% | 23.0% | $355.03 | |
|
QCOM
QUALCOMM Incorporated
|
NEUTRAL | $172.01B | 31.88 | 23.3% | 12.5% | $159.42 | |
|
ANET
Arista Networks, Inc.
|
NEUTRAL | $171.69B | 52.64 | 31.7% | 39.7% | $136.34 |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-20 | CLIFFORD KATHERINE LEE | Officer | Sale | 681 | $191,108 |
| 2026-01-14 | SHARMA MANISH | Officer | Sale | 2,731 | $786,871 |
| 2026-01-14 | MACCHI MAURO | Officer | Sale | 500 | $140,000 |
| 2026-01-14 | SWEET JULIE SPELLMAN | Chief Executive Officer | Sale | 1,694 | $488,380 |
| 2026-01-07 | MACCHI MAURO | Officer | Sale | 500 | $140,000 |
| 2026-01-06 | UNRUCH JOEL SCOTT | General Counsel | Sale | 1,332 | $366,300 |
| 2026-01-05 | WALSH JOHN F | Officer | Stock Award | 1,760 | $27,364 |
| 2026-01-05 | UNRUCH JOEL SCOTT | General Counsel | Stock Award | 1,431 | $27,627 |
| 2026-01-05 | SHARMA MANISH | Officer | Stock Award | 1,173 | $18,418 |
| 2026-01-05 | PARK ANGIE Y | Chief Financial Officer | Stock Award | 1,097 | $27,627 |
| 2026-01-05 | CLIFFORD KATHERINE LEE | Officer | Stock Award | 538 | $17,365 |
| 2026-01-05 | HOGAN CATHERINE KIERNAN | Chief Operating Officer | Stock Award | 914 | $21,312 |
| 2026-01-05 | BURGUM MELISSA A | Officer | Stock Award | 674 | $19,997 |
| 2026-01-05 | SWEET JULIE SPELLMAN | Chief Executive Officer | Stock Award | 3,477 | $38,678 |
| 2025-12-31 | WALSH JOHN F | Officer | Stock Award | 5,192 | - |
Insider transactions can signal confidence or concerns about company prospects
Wall Street Analysts
Professional analyst ratings and price targets
Consensus
BUY
27 analysts
Wells Fargo
2026-01-14
Equal-Weight
Equal-Weight
Truist Securities
2026-01-06
Buy
UBS
2025-12-19
Buy
Buy
Susquehanna
2025-12-19
Neutral
Neutral
RBC Capital
2025-12-19
Outperform
Outperform
Morgan Stanley
2025-12-16
Equal-Weight
Overweight
Citigroup
2025-10-22
Neutral
Wells Fargo
2025-10-22
Equal-Weight
Mizuho
2025-09-29
Outperform
Outperform
BMO Capital
2025-09-26
Market Perform
Market Perform
Past News Coverage
Recent headlines mentioning ACN from our newsroom.
Newest → oldest
No matching news yet.